December 5, 2019
A research team led by biomedical scientists at the University of California, Riverside, has found that a drug approved by the FDA to treat rheumatoid arthritis and ulcerative colitis can repair permeability defects in the gut’s epithelium. Affecting roughly 1 million Americans, ulcerative colitis is a chronic inflammatory bowel disease of […]